Position in PFE
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$649,773
-$201,724 QoQ
Shares Held
26,984
-11.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#1,580
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Montecito Bank & Trust holds $27,844,791 across 8 Drug Manufacturers - General names. PFE ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,044 | $10,847,645 | |
| 2 | ABBV |
AbbVie Inc.
|
29,468 | $7,415,326 | |
| 3 | JNJ |
Johnson & Johnson
|
17,089 | $4,340,092 | |
| 4 | MRK |
Merck & Co., Inc.
|
21,223 | $2,727,155 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
6,872 | $868,208 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
12,596 | $725,780 | |
| 7 | PFE |
Pfizer Inc
This page
|
26,984 | $649,773 | |
| 8 | NVS |
Novartis AG
|
1,728 | $270,812 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $649,773 | 26,984 | Shares | Defined | 2026-07-16 | |
| 2026-03-31 | $851,497 | 30,324 | Shares | Defined | 2026-04-16 | |
| 2025-12-31 | $755,739 | 30,351 | Shares | Defined | 2026-01-09 | |
| 2025-09-30 | $778,337 | 30,547 | Shares | Defined | 2025-10-07 | |
| 2025-03-31 | $961,373 | 37,939 | Shares | Defined | 2025-04-17 | |
| 2024-12-31 | $1,101,578 | 41,522 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $1,203,671 | 41,592 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $1,017,771 | 36,375 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $1,125,012 | 40,541 | Shares | Sole | 2024-04-09 | |
| 2023-12-31 | $1,201,118 | 41,720 | Shares | Sole | 2024-01-05 | |
| 2023-09-30 | $1,643,970 | 49,562 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $1,942,242 | 52,951 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $2,293,286 | 56,208 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $2,896,750 | 56,533 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $2,523,289 | 57,662 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $3,440,351 | 65,618 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $3,674,375 | 70,975 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $4,324,703 | 73,238 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $3,175,900 | 73,841 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $2,866,041 | 73,188 | Shares | Sole | 2021-07-08 | |
| 2021-03-31 | $2,545,229 | 70,252 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $2,483,681 | 67,473 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $2,426,637 | 66,121 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $1,927,470 | 58,944 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $2,055,402 | 62,972 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||